A Study to Assess the Effects of Epetraborole on the QT Interval in Healthy Adult Subjects
Status:
Completed
Trial end date:
2023-08-03
Target enrollment:
Participant gender:
Summary
A single-center, 4-way crossover study to evaluate the effect of single therapeutic and
supratherapeutic oral doses of epetraborole on the heart rate (HR) corrected QT interval
(QTc) by assessing concentration-QT (C-QT) relationship using exposure-response modeling.